Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2024

  1. Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)

    The Lancet Regional Health - Europe, Vol. 40

  2. Corrigendum to “Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI)” [The Lancet Regional Health – Europe 40 (2024) 100892] (The Lancet Regional Health - Europe (2024) 40, (S2666776224000589), (10.1016/j.lanepe.2024.100892))

    The Lancet Regional Health - Europe

  3. Renal Function Impairment in Children With Congenital Cytomegalovirus Infection: A Cross-sectional Study

    The Pediatric infectious disease journal, Vol. 43, Núm. 3, pp. 257-262

  4. T-Cell Immune Responses in Newborns and Long-Term Sequelae in Congenital Cytomegalovirus Infection (CYTRIC Study)

    Journal of Pediatrics, Vol. 272

  5. Tuberculosis Disease in Immunocompromised Children and Adolescents: A Pediatric Tuberculosis Network European Trials Group Multicenter Case-control Study

    Clinical Infectious Diseases, Vol. 79, Núm. 1, pp. 215-222

2023

  1. The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmission

    PLoS ONE, Vol. 18, Núm. 2 February

2022

  1. Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study

    Thorax, Vol. 77, Núm. 10, pp. 1023-1029

  2. Children living with HIV in Europe: do migrants have worse treatment outcomes?

    HIV Medicine, Vol. 23, Núm. 2, pp. 186-196

  3. Impact of the COVID-19 Pandemic on the Diagnosis of Congenital Cytomegalovirus Infection in Spain

    Pediatric Infectious Disease Journal, Vol. 41, Núm. 7, pp. 590-592

  4. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort

    Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768

  5. Rituximab as Second-Line Treatment in Anti-NMDAR Encephalitis after Herpes Simplex Encephalitis in Children

    Indian Journal of Pediatrics, Vol. 89, Núm. 10, pp. 1031-1033

  6. Treatment and Outcome in Children With Tuberculous Meningitis: A Multicenter Pediatric Tuberculosis Network European Trials Group Study

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 3, pp. 372-381

2021

  1. Interferon-Gamma Release Assays Differentiate between Mycobacterium avium Complex and Tuberculous Lymphadenitis in Children

    Journal of Pediatrics, Vol. 236, pp. 211-218.e2

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Growth Patterns in Children with Congenital Cytomegalovirus Infection

    Pediatric Infectious Disease Journal, pp. 1230-1235

  3. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  4. Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: A multicentre paediatric tuberculosis network european trials group (ptbnet) study

    European Respiratory Journal, Vol. 56, Núm. 1

2019

  1. Is Polymerase Chain Reaction in Neonatal Dried Blood Spots Reliable for the Diagnosis of Congenital Cytomegalovirus Infection?

    The Pediatric infectious disease journal, Vol. 38, Núm. 5, pp. 520-524

  2. Role of magnetic resonance imaging and cranial ultrasonography in congenital cytomegalovirus infection

    Pediatric Infectious Disease Journal, Vol. 38, Núm. 11, pp. 1131-1137

2017

  1. Cytomegalovirus DNA Detection by Polymerase Chain Reaction in Cerebrospinal Fluid of Infants with Congenital Infection: Associations with Clinical Evaluation at Birth and Implications for Follow-up

    Clinical Infectious Diseases, Vol. 64, Núm. 10, pp. 1335-1342